AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) have voluntarily withdrawn the marketing authorization application in the EU for datopotamab deruxtecan for the treatment of adult patients with ...
Three late-breaking presentations across lung and breast cancer trials of three DXd ADCs to be showcased Science & Technology Day to provide overview of data and strategy across Daiichi Sankyo R&D ...
(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) said that they have voluntarily withdrawn their marketing authorisation application (MAA) in the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback